Come up with a name for your new list and we'll add to it:
Celator Pharmaceuticals raised a round of funding on May 01, 2013. Investors include
Valence Life Sciences.
Celator Pharmaceuticals is a pharmaceutical company developing new and effective therapies to treat cancer. CombiPlex, the company's drug ratio technology platform, represents an approach that identif…